Syndromic Surveillance for E-Cigarette, or Vaping, Product Use-Associated Lung Injury
- 20 February 2020
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 382 (8), 766-772
- https://doi.org/10.1056/NEJMsr1915313
Abstract
Increases in EVALI were identified in 2019. Using the National Syndromic Surveillance Program, which includes about 70% of U.S. EDs, researchers found a gradual increase in ED visits associated with shortness of breath and e-cigarette use from January 2017 through early June 2019. A sharp increase was identified in June, peaking in September. A subsequent decrease was observed.This publication has 11 references indexed in Scilit:
- Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin - Final ReportThe New England Journal of Medicine, 2020
- e-Cigarette Use Among Youth in the United States, 2019JAMA, 2019
- Nicotine Absorption Profile Among Regular Users of a Pod-Based Electronic Nicotine Delivery SystemJAMA Network Open, 2019
- Characteristics of a Multistate Outbreak of Lung Injury Associated with E-cigarette Use, or Vaping — United States, 2019Morbidity and Mortality Weekly Report (MMWR), 2019
- Clinicians’ Guide to Cannabidiol and Hemp OilsMayo Clinic Proceedings, 2019
- Google Trends in Infodemiology and Infoveillance: Methodology FrameworkJMIR Public Health and Surveillance, 2019
- Using Syndromic Surveillance for All-Hazards Public Health Surveillance: Successes, Challenges, and the FuturePublic Health Reports, 2017
- The Evolution of BioSense: Lessons Learned and Future DirectionsPublic Health Reports, 2017
- tidytext: Text Mining and Analysis Using Tidy Data Principles in RThe Journal of Open Source Software, 2016
- Estimating regression models with unknown break‐pointsStatistics in Medicine, 2003